FDA Approved: CINACALCET — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cinacalcet (Cipla USA Inc.), resulting in changes to CINACALCET's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

SUPPL AP for CINACALCET (CINACALCET)